TopStocks.com - Premium Stock Alerts

    Sponsored

    TopStocks Alert: (Nasdaq:INBS)

    July 15, 2026

    Greetings Readers,

    A Nasdaq-listed medical technology company is scaling a category that most investors still associate with slow, invasive workflows: drug testing.

    Instead of urine cups, chain-of-custody logistics, and long lab turnaround times, this company is commercializing a non-invasive fingerprint sweat drug screening system designed for rapid collection in seconds and results in under 10 minutes — a workflow advantage that matters most in safety-critical industries where time, hygiene, and compliance friction can make or break adoption.

    And the traction isn’t theoretical: the company reports 450+ active customer accounts across 24 countries, with use cases spanning construction, mining, manufacturing, transport/logistics, drug treatment, law enforcement, and forensics.

    Now add a steady stream of fresh press releases — including global distribution expansion, record revenue milestones, and updated FDA progress — and you’ll see why this Nasdaq profile has been lighting up watchlists.

    Here's what's happening with this Nasdaq medtech name:

    Intelligent Bio Solutions Inc. (NASDAQ: INBS)

    Intelligent Bio Solutions is a rapid, non-invasive testing company best known for the Intelligent Fingerprinting Drug Screening System — a portable platform designed to detect recent drug use from fingerprint sweat, with sample collection in seconds and results in under ten minutes.

    According to the company, INBS now supports 450+ accounts across 24 countries, with ongoing adoption across multiple industries. (Company Overview)

    And based on accelerating global adoption plus a defined U.S. regulatory roadmap — INBS has secured a top position on my watchlist heading into 2026.

    Breaking News: INBS Provides Updated Timeline for FDA 510(k) Submission and Clearance

    INBS recently provided an updated pathway for its anticipated FDA 510(k) clearance process, noting it plans to conduct additional clinical studies to strengthen its new submission and that it anticipates FDA 510(k) clearance in the second half of 2026.

    Source: INBS Investor Relations (FDA 510(k) timeline update)

    What This Means For Investors

    INBS now has multiple catalysts working in parallel:

    • Global adoption already in motion: INBS reports it has surpassed 450 active accounts across 24 countries, driven by new account wins and deeper penetration into safety-critical industries. (Global adoption update)
    • Distributor expansion that can scale faster than direct sales: INBS highlighted regional growth momentum via partnerships — including a release describing expanding adoption across Scandinavia. (Scandinavia PR)
    • Record revenue milestone (early signal of scaling): The company announced preliminary results indicating over $1.0M in fiscal Q1 2026 revenue — described as a company record — with year-over-year increases in both cartridge and reader revenue. (8-K / earnings release)
    • A clear “comparison edge” vs. legacy drug testing: Fingerprint sweat testing can be positioned as faster, more hygienic, and operationally simpler than lab-based workflows — which may improve compliance and reduce downtime in high-volume screening environments (transportation, construction, mining, and logistics).
    • Capital-structure housekeeping: INBS announced a reverse split process (board-determined ratio within an authorized range), a typical step micro-caps use to meet listing requirements and improve flexibility for institutional access. (Reverse split PR)

    Here Are the Key Catalysts Coming Into Focus:

    • 450+ accounts across 24 countries already using the platform
    • Ongoing distributor-driven expansion (including Scandinavia)
    • Record revenue milestone as cartridge and reader volumes scale
    • Defined FDA path targeting anticipated 510(k) clearance in 2H 2026
    • A workflow advantage vs. urine/saliva testing: fast, non-invasive, lower-friction screening

    More on each of these in a moment.

    Learn more at https://investors.ibs.inc/

    Add Intelligent Bio Solutions Inc. (NASDAQ: INBS) to your radar.

    Enjoyed this breakdown?

    Don't miss our next early stock alert.
    Join our SMS list and get real time picks sent straight to your phone the moment we release them.

    Get Instant SMS Alerts

    Fast, free, zero spam. Opt out anytime.

    By joining, you agree to receive recurring SMS alerts from TopStocks. Message and data rates may apply. Reply STOP to unsubscribe.

    MASTER LEGAL DISCLAIMER

    Last Updated: Dec 17, 2025

    Publisher: Relqo Media LLC (Wyoming, United States)

    Subject Company: Intelligent Bio Solutions Inc. (INBS)

    IMPORTANT SUMMARY — PLEASE READ FIRST

    This website and all affiliated digital materials are published by Relqo Media LLC, a Wyoming marketing agency that has been compensated in cash by YachtXotics Enterprises Inc. and Uptic Analytics LLC to produce and distribute promotional content regarding Intelligent Bio Solutions Inc. (NASDAQ, INBS). This communication is a paid advertisement, not a research report, not investment advice, and not an independent publication. Relqo Media is not a broker-dealer, investment adviser, or securities analyst. Investing in small-cap or microcap securities is highly speculative and may result in the complete loss of your investment. All viewers are strongly urged to consult with a licensed investment professional and perform their own due diligence.

    1. NATURE AND INTENT OF THIS COMMUNICATION

    Relqo Media LLC is a for-profit marketing agency engaged in paid promotional campaigns for public companies. The content we create is strictly commercial and is intended to generate temporary public awareness, visibility, and short-term market attention for the featured company. This material is not impartial. All readers should interpret our content as a paid commercial advertisement and not as an editorial, research article, or independent analysis. We produce advertisements, not investment research. These communications are not designed to provide factual evaluations of the company's business operations or investment merit.

    2. COMPENSATION FOR Intelligent Bio Solutions Inc. (INBS)

    Relqo Media LLC has been contracted by YachtXotics Enterprises Inc. and Uptic Analytics LLC to provide investor awareness and advertising services for Intelligent Bio Solutions Inc. (NASDAQ, INBS). These arrangements involve monetary compensation in exchange for creating and distributing promotional content across multiple digital channels.

    Relqo Media LLC has received or will receive the following compensation for INBS promotional services:

    • $20,000 for a campaign running from November 30, 2025 through December 17, 2025 paid by Uptic Analytics LLC.
    • $14,200 for a campaign running from June 25, 2025 through June 26, 2025 paid by YachtXotics Enterprises Inc.
    • $10,000 for a campaign running from July 13, 2025 through July 14, 2025 paid by YachtXotics Enterprises Inc.
    • $20,000 for a digital campaign running from July 14, 2025 through July 15, 2025 paid by YachtXotics Enterprises Inc.

    YachtXotics Enterprises Inc., Uptic Analytics LLC, and or their affiliates may own, acquire, or sell securities of INBS before, during, or after the promotional period. Uptic Analytics LLC currently owns shares of INBS, which represents an additional material conflict of interest. Any ownership interests, whether past, present, or future, must be assumed to influence the promotional content distributed for this campaign. All promotional materials produced by Relqo Media LLC regarding INBS should be viewed as biased, financially motivated content created for the benefit of the paying entities.

    Relqo Media LLC does not represent itself as a licensed broker-dealer, registered investment adviser, or financial analyst. Nothing in our content should be interpreted as investment advice, an offer to buy or sell securities, or a recommendation to engage in any investment activity.

    Readers should perform independent due diligence, consult with licensed financial professionals, and assume that any statements made about INBS are materially influenced by compensation and the ownership interests of the paying clients.

    Neither Relqo Media LLC, YachtXotics Enterprises Inc., nor Uptic Analytics LLC guarantee the accuracy, timeliness, or completeness of the information provided. All parties disclaim any liability for investment losses that may occur as a result of reliance on our promotional materials.

    3. INTENDED AUDIENCE

    These Communications are directed solely to U.S.-based, self-directed investors who understand the risks of investing in microcap and Nasdaq-listed securities. The content is not intended for children, seniors, retirement accounts, or individuals with limited experience in securities trading. These Communications are not intended to guide investment for long-term portfolio management or financial planning purposes.

    4. NO ENDORSEMENT OR VERIFICATION OF COMPANY CLAIMS

    Relqo Media LLC does not, and has not, independently verified, investigated, audited, or substantiated any statements, representations, or claims made by the featured company, its officers, directors, employees, affiliates, agents, press releases, marketing materials, or any third-party sources.

    Any and all information regarding Intelligent Bio Solutions Inc. (NASDAQ: INBS)—including but not limited to business descriptions, operational updates, clinical trial progress, scientific data, partnerships, revenue projections, market opportunity estimates, or strategic plans—should be assumed to be unverified, unaudited, incomplete, potentially inaccurate, and subject to change without notice.

    We make no warranties or representations as to the truthfulness, accuracy, reliability, or completeness of such information, and you should not interpret our publication of these statements as an endorsement or confirmation of their validity.

    You should not rely on any company-provided claims, projections, or forward-looking statements for the purpose of making an investment decision. All such statements may be speculative, overstated, selectively presented, or based on assumptions that may never materialize.

    If you choose to invest, you do so entirely at your own risk, and you should conduct thorough, independent due diligence—including reviewing SEC filings, consulting licensed investment professionals, and obtaining independent verification of any material facts—before making any investment decision.

    5. MARKET INFLUENCE AND TRADING PATTERN EXPECTATION

    Historically, promotional campaigns for microcap and small-cap securities—particularly those driven by paid advertising—often cause temporary, artificial, and unsustainable increases in share price and trading volume. These movements are typically fueled by short-term speculative interest, promotional circulation, algorithmic trading activity, and momentum-based retail buying rather than any change in the underlying business, operations, or financial condition of the company.

    You should assume and expect that:

    • INBS's share price may experience sharp, rapid, and potentially extreme increases during the period of active promotion;
    • Trading volume may spike dramatically due to speculative buying pressure, news catalysts amplified by promotional activity, and social media or online forum chatter;
    • Once buying interest subsides, selling begins, or the promotion ends—which may occur suddenly and without notice—the share price may decline precipitously, potentially returning to pre-promotion levels or lower, often within days or even hours; and
    • These price and volume movements are not reflective of intrinsic value and may have no correlation to the company's actual fundamentals or long-term business prospects.

    Past market behavior shows that such promotional price spikes are frequently followed by steep losses, which can be rapid and irreversible. If you purchase shares during or shortly after a promotional period, you should be prepared for the high probability of losing a substantial portion, or all, of your investment.

    By engaging with our content, you acknowledge and agree that you fully understand the speculative, volatile, and high-risk nature of securities subject to promotional activity, and you will not hold Relqo Media LLC responsible for any losses resulting from such trading patterns.

    6. NO RELIANCE – INVESTOR RESPONSIBILITY

    The burden of research, verification, and risk assessment rests entirely with you, the reader. All content produced and distributed by Relqo Media LLC is promotional in nature and should not be the basis for any investment decision. We are not responsible for your interpretation or use of the information contained herein.

    You are solely responsible for:

    • Reviewing and analyzing all publicly available information, including but not limited to SEC filings, audited financial statements, and official company disclosures;
    • Consulting with a licensed, qualified investment professional, attorney, or tax adviser before making any investment decision;
    • Understanding and accepting the risks inherent in microcap and early-stage public companies, which may include extreme volatility, illiquidity, lack of financial transparency, insider selling, share dilution, regulatory challenges, and business failure.

    We make no warranties or representations as to the accuracy, completeness, timeliness, or reliability of any information presented. Any data, figures, or statements regarding the featured company's business, market opportunity, future performance, or partnerships may be incomplete, outdated, or incorrect. You should assume that certain information is based on third-party sources we have not independently verified.

    By viewing our materials, you agree that:

    • You will not rely solely on our communications in making an investment decision;
    • You accept full responsibility for conducting independent due diligence; and
    • Relqo Media LLC and its affiliates will not be liable for any losses or damages arising from your reliance on our content.

    7. FORWARD-LOOKING STATEMENTS, ASSUMPTIONS, AND ACCURACY NOTICE

    Our materials may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as well as other predictive or aspirational language regarding future events, performance, or results. Words such as "anticipates," "expects," "intends," "plans," "believes," "may," "will," "should," "could," "projects," "estimates," "potential," and similar expressions are intended to identify such statements. These statements are inherently uncertain, based on current expectations, estimates, and assumptions that may prove to be incorrect, incomplete, or no longer applicable at the time you read them.

    Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. Such factors include, but are not limited to: changes in market conditions, regulatory decisions, the outcome of clinical trials, competitive pressures, the availability of financing, and broader economic or geopolitical developments.

    Additionally, some information presented in our content is derived from third-party sources, company press releases, or statements from officers, directors, or affiliates of the featured company. We do not independently verify or guarantee the accuracy, completeness, or timeliness of such information. Any claim, projection, or forward-looking statement should be considered purely speculative and potentially outdated..

    You should not place undue reliance on forward-looking statements or assume that they will prove to be accurate. Relqo Media LLC undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events, changes in circumstances, or the emergence of new information, except as required by law.

    8. INFORMATION SOURCING, BIAS, AND ACCURACY

    We use publicly available information including company websites, press releases, and promotional materials supplied by paying clients or related parties. We do not verify or validate this data.

    Assume all information presented by Relqo Media is:

    • Subjective,
    • Not independently verified,
    • Created to highlight potential upside and omit downsides,
    • Not suitable as the basis for any investment decision.

    9. OWNERSHIP AND TRADING CONFLICTS

    Relqo Media LLC, its contractors, members, and affiliates may hold or acquire shares in the companies we promote, including INBS. We may buy or sell such shares without prior notice. These transactions may occur before, during, or after a promotional campaign and may affect market pricing. We are not obligated to update readers on our trading activity or affiliate holdings.

    10. MARKETING TOOLS, DATA COLLECTION, AND USER CONSENT

    We use a range of outreach and promotional tools, including:

    • Email and newsletter distributions,
    • SMS/MMS text campaigns,
    • Social media posts and influencers,
    • Google and native display ads,
    • Press releases, video marketing, and paid content distribution.

    By engaging with our content, you consent to receive ongoing marketing communications. You may unsubscribe, but your data may be retained for audit or compliance purposes. Please refer to our Privacy Policy for further details.

    11. ADVERTISING LAW COMPLIANCE

    Relqo Media LLC produces promotional content in accordance with the advertising disclosure standards set forth by the Federal Trade Commission (FTC) and the SEC's interpretations of sponsored investment-related communications.

    We make good-faith efforts to disclose all:

    • Compensation arrangements,
    • Conflicts of interest,
    • Risks,
    • Limitations of our role, and
    • The promotional nature of this content.

    We do not provide investment recommendations under any regulatory framework including, but not limited to, SEC Regulation Analyst Certification, FINRA Rule 2210, or Regulation Best Interest.

    12. NON-U.S. USERS

    This material is intended solely for distribution within the United States. If you are accessing this site from outside the U.S., you are responsible for complying with your country's laws. Relqo Media disclaims liability for access from non-U.S. jurisdictions where investor promotion, marketing, or solicitation of securities is restricted or prohibited.

    13. DISCLAIMER OF WARRANTIES AND LIMITATION OF LIABILITY

    All content is provided "as-is" and without warranties of any kind, either express or implied. Relqo Media LLC disclaims any and all liability for:

    • Investment losses,
    • Inaccuracies,
    • Technical delays,
    • User misunderstandings,
    • Omissions or errors in content.

    Total liability for any claim shall not exceed one hundred dollars ($100).

    14. LEGAL GOVERNANCE AND DISPUTE RESOLUTION

    All matters arising out of this disclaimer shall be governed by the laws of the State of Wyoming. You agree that any dispute shall be resolved exclusively through binding arbitration under the rules of the American Arbitration Association, to be held in Sheridan County, Wyoming. Class action claims and group arbitration are expressly prohibited.

    15. NON-SOLICITATION AND GEOGRAPHIC LIMITATIONS

    Nothing in our content constitutes a general solicitation or a personal securities recommendation. If you reside in a jurisdiction where such communications are unlawful, you must exit this site and discontinue engagement with our content.

    16. FINAL NOTICE – ACCEPTANCE OF TERMS

    We reserve the right to update this Disclaimer at any time without notice. Your continued use of our services or content constitutes acceptance of the most recent version.

    If you do not accept all terms of this disclaimer in full, you must:

    • Exit our websites,
    • Unsubscribe from our communications,
    • Discontinue viewing all Relqo Media promotional content.

    17. NO RELIANCE

    By viewing or engaging with this content, you agree that:

    • You will not rely on any statements made by Relqo Media for investment purposes,
    • You waive any claim that our content was a material factor in your investment decision,
    • You have read, understood, and accepted this disclaimer in full.

    © 2024 Relqo Media LLC. All Rights Reserved.

    Legal Contact: 📧 support@topstocks.com

    Mailing Address: 1309 Coffeen Ave Ste 1200, Sheridan, WY 82801

    Affiliate Disclosure: Relqo Media LLC owns and operates TopStocks.com and all affiliated digital properties.